Vaibhav Sahai

33PUBLICATIONS
283CO-AUTHORS
Molecular targetsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electronic and magnetic properties of condensed matter; superconductivity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Oct 16, 2026
Cobimetinib + Vemurafenib in Patients With BRAF V600E-Mutant Papillary Thyroid and Biliary Tract Cancers: Results From the TAPUR Study.

|Oct 12, 2026
Real-world analysis of genotype-guided treatment for carriers of actionable DPYD and UGT1A1 variants.

|Sep 21, 2026
Longitudinal Analysis of Matched Patient Biospecimens Reveals Neural Reprogramming of Cancer-Associated Fibroblasts Following Chemotherapy in Pancreatic Cancer.

|Jul 23, 2026
A Phase II Multicenter Trial of Rucaparib and Nivolumab as Maintenance Therapy in Patients with Advanced Biliary Tract Cancer: BilT-02.

|Jul 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

|Apr 28, 2026
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer.

Pageof 6

Frequent Collaborators

6 joint publications

Jiaqi Shi

5 joint publications

Valerie Gunchick

5 joint publications

Filip Bednar

5 joint publications

Timothy L Frankel